| 000 | 01405 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250517184234.0 | ||
| 264 | 0 | _c20180914 | |
| 008 | 201809s 0 0 eng d | ||
| 022 | _a1432-1041 | ||
| 024 | 7 |
_a10.1007/s00228-017-2348-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKheloufi, Farid | |
| 245 | 0 | 0 |
_aPerampanel-associated self-harm ideation after dosage increase. _h[electronic resource] |
| 260 |
_bEuropean journal of clinical pharmacology _cFeb 2018 |
||
| 300 |
_a243-244 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Letter | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aCarbamazepine _xanalogs & derivatives |
| 650 | 0 | 4 |
_aDrug Resistant Epilepsy _xdrug therapy |
| 650 | 0 | 4 |
_aDrug Therapy, Combination _xadverse effects |
| 650 | 0 | 4 |
_aEpilepsies, Partial _xdrug therapy |
| 650 | 0 | 4 |
_aEpilepsy, Tonic-Clonic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aNitriles |
| 650 | 0 | 4 | _aOxcarbazepine |
| 650 | 0 | 4 |
_aPyridones _xadverse effects |
| 650 | 0 | 4 |
_aSelf Mutilation _xchemically induced |
| 700 | 1 | _aDefault, Anne | |
| 700 | 1 | _aPerrouty, Bruno | |
| 700 | 1 | _aBlin, Olivier | |
| 700 | 1 | _aMicallef, Joëlle | |
| 773 | 0 |
_tEuropean journal of clinical pharmacology _gvol. 74 _gno. 2 _gp. 243-244 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00228-017-2348-6 _zAvailable from publisher's website |
| 999 |
_c27779586 _d27779586 |
||